• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Pfizer

Paxlovid (nirmatrelvir + ritonavir)
Posted inCOVID-19, Infections, Regulatory

Paxlovid for COVID-19 Treatment. All Details

August 24, 2022November 28, 2022

Paxlovid: treatment efficacy, “Paxlovid mouth”, COVID-19 rebound, management of Omicron variant, treatment resistance, generics, mechanism of action, price.

alopecia areata
Posted inAutoimmune Diseases, Clinical Trials, In the Pipeline, New Drugs, Regulatory

Alopecia Areata Treatment: What Future Holds

August 3, 2022September 8, 2022

What new drugs for hair loss are being developed by the pharmaceutical industry?

psoriasis
Posted inAutoimmune Diseases, New Drugs, Regulatory

Zoryve: New Effective Cream for Psoriasis

August 1, 2022September 8, 2022

Roflumilast will cure plaque psoriasis in half of patients.

Monkeypox 2022. Full Review
Posted inInfections, Research

Monkeypox 2022. Full Review

June 1, 2022September 12, 2022

Monkeypox as a new threat to humanity.

agitation
Posted inNeuroscience, New Drugs, Regulatory

Igalmi: New Drug for Agitation in Schizophrenia and Bipolar Disorder

April 7, 2022September 8, 2022

BioXcel Therapeutics has offered a fast-action mouth-dissolving sublingual film formulation of dexmedetomidine.

Paxlovid (nirmatrelvir + ritonavir).
Posted inCOVID-19, Infections, Research

Paxlovid Works Against Omicron

January 18, 2022September 8, 2022

The newest COVID-19 treatment is highly effective against the Omicron variant of SARS-CoV-2 coronavirus.

coronavirus
Posted inCOVID-19, Infections, Research

Three Billion Omicron Cases

December 25, 2021September 8, 2022

Omicron, a new variant of the SARS-CoV-2 coronavirus, will infect nearly 40% of the world’s population.

Posts navigation

Newer posts 1 2 3 4 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News